Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors
- DOI
- 10.36401/jipo-25-38
- Published
- 2026-09-29
- Container
- Journal of Immunotherapy and Precision Oncology
- Publisher
- Innovative Healthcare Institute
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.36401/jipo-25-38,
title = {Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors},
author = {Mohamed A. Gouda and Heather Lin and Lei Kang and Hung Le and Ecaterina E. Dumbrava and Siqing Fu and Daniel D. Karp and Apostolia Tsimberidou and Aung Naing and Sarina A. Piha-Paul and Paula Pohlmann and Jordi Rodon and Timothy A. Yap and Funda Meric-Bernstam and David S. Hong},
year = {2026},
journal = {Journal of Immunotherapy and Precision Oncology},
doi = {10.36401/jipo-25-38},
url = {https://doi.org/10.36401/jipo-25-38}
}RIS
TY - JOUR TI - Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors AU - Mohamed A. Gouda AU - Heather Lin AU - Lei Kang AU - Hung Le AU - Ecaterina E. Dumbrava AU - Siqing Fu AU - Daniel D. Karp AU - Apostolia Tsimberidou AU - Aung Naing AU - Sarina A. Piha-Paul AU - Paula Pohlmann AU - Jordi Rodon AU - Timothy A. Yap AU - Funda Meric-Bernstam AU - David S. Hong PY - 2026 JO - Journal of Immunotherapy and Precision Oncology DO - 10.36401/jipo-25-38 UR - https://doi.org/10.36401/jipo-25-38 ER -
APA
Gouda, M. A., Lin, H., Kang, L., Le, H., Dumbrava, E. E., Fu, S., Karp, D. D., Tsimberidou, A., Naing, A., Piha-Paul, S. A., Pohlmann, P., Rodon, J., Yap, T. A., Meric-Bernstam, F., & Hong, D. S. (2026). Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors. Journal of Immunotherapy and Precision Oncology. https://doi.org/10.36401/jipo-25-38
Source records
- crossref · retrieved 2026-11-10T11:32:07.265Z